President Joe Biden has announced his intention to appoint Dr. Renee Wegrzyn as the first director of the Advanced Research Projects Agency for Health (ARPA-H), a new agency focused on biomedical innovation. Dr. Wegrzyn has experience working for the Defense Advanced Research Projects Agency (DARPA) and Intelligence Advanced Research Projects Activity (IARPA), which inspired the creation of ARPA-H. She will be responsible for driving the agency's research portfolio and budget, which is expected to support programs aimed at preventing, detecting, and treating diseases like cancer. ARPA-H was established in March 2022 to push the boundaries of biomedical and health research and innovation. The agency will tap into talent from industry, academia, and government, and will prioritize equity in its mission to support breakthroughs, expand healthcare access, and improve access for all patients. Dr. Wegrzyn is currently a vice president at Ginkgo Bioworks and has experience in synthetic biology, biosecurity, and gene editing. She holds a doctorate and bachelor's degrees in applied biology and has received recognition for her work in the field.